Year in Review: The 8 Most Important Lab Compliance Stories of 2023
Though things appeared status quo in 2023, last year may prove to be a turning point for the laboratory industry.
Though things appeared status quo in 2023, last year may prove to be a turning point for the laboratory industry.
Comments on the FDA’s proposed rule to regulate LDTs as in vitro diagnostic devices reveal mixed reactions.
Genialis CEO and co-founder Rafael Rosengarten, PhD, discusses key 2023 AI developments and what they could mean for laboratories.
G2 Intelligence to change subscription model to better serve the laboratory industry with more analysis and insight
Our upcoming event will provide lab leaders with analysis of recent legal and regulatory developments, enforcement trends, and more